Avid Bioservices Inc (CDMO)

[north40000]

In light of PPHM's pancreatic trial, I thought there might be some interest in this 3 1/2' video re GVAX vaccine trial at Johns Hopkins
from perspective of 3 doctors and 2 patients, one surviving 6 years and the other ~12 years:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110427280

Another prospective paradign shift, now-highly profitable, investment[ANIP], arising out of long-in-the-red Biosante.

Unexpected perhaps, but shows how a once losing investment of long standing can become very profitable, currently a little less than 400% return for us. All told, we have held our PPHM shares for a shorter time.

This GVAX vaccine is administered before surgery. Tumor microenvironment was changed as a result, per observations.